A gummy contract manufacturing agreement is where a good product idea either becomes a defensible asset or quietly becomes somebody else's. Most buyers spend their energy on the formula and the flavour, then sign a document that leaves the three ownership questions unanswered: who owns the mould, who owns the formula, and what "exclusivity" actually commits the factory to. We manufacture gummies across 19 SKUs, hold more than 200 patents across the group, and ship to more than 40 markets. This page is the contract literacy we wish every first-time buyer brought to the table — written for the person who has to sign, not just the person who tastes the sample.

Three contracts, not one
Buyers often expect a single "manufacturing agreement" to cover everything. In practice the relationship rests on three layers, and each protects a different thing. As of 2026 this is the standard way contract manufacturers and brand owners structure a gummy program.
| Document | When it is signed | What it protects |
|---|---|---|
| Non-disclosure agreement (NDA) | Before any formula, spec or prototype is shared | Your confidential information and trade secrets |
| Development agreement | Before paid R&D, tooling or trial batches begin | Who owns what gets created, and tooling collection rights |
| Supply agreement | Before the first production order | Quality, exclusivity, documentation and continuity of supply |
If a factory wants you to skip straight to the supply agreement and "sort the IP later", that sequencing is itself information. Ask for the NDA first. Share information in stages — category, target actives and volume expectations at the inquiry stage; the full formula only with the one or two factories you are seriously evaluating, and only after the NDA is signed and returned.
Who owns the mould
In gummy manufacturing the mould is not a detail — it is the product. A custom sculpt and its cavity determine the piece weight, the depositing behaviour and the eating experience. A shape that is unique to your brand is an asset, and an asset needs an owner written into a document.
Three questions belong in the development agreement: who paid for the tooling, who keeps physical possession of it, and under what condition it can be collected or moved. Industry practice, as of 2026, is to settle tooling ownership and collection rights in the development agreement and to tie release to the final invoice, rather than discovering the disagreement on the day you want to move production. Specify whether the same mould may be used for another buyer. A factory that will not answer that question in writing is telling you the answer.

Who owns the formula
Formula ownership is a contract question, not an invoice question. As of 2026 the general rule published by contract manufacturers is straightforward: if you bring a finished formula and the factory only produces it, ownership normally stays with you; if the factory develops the formula, or you start from a stock formula, ownership usually stays with the factory unless the agreement says otherwise. A right-to-use clause is not a transfer of ownership.
The awkward case is scale-up. Your recipe meets the factory's R&D team, pH gets adjusted, a flavour system is swapped, drying parameters move — and the "improved" formula is now partly their work. Decide up front who owns those modifications. Ask for three things in writing before development starts: who owns the final formula and every revision, whether the factory may offer the same formula to other brands, and whether you can take it to another manufacturer. Be careful with a waived development fee: in the open literature it is described as a signal that a factory intends to keep the formula and recover that value elsewhere. We do not comment on any individual factory's motives — we only insist the ownership line is written down.
The exclusivity clause has four coordinates
"We will give you exclusivity" is not a clause; it is a conversation. An exclusivity promise that does not name four coordinates is unenforceable in practice and worthless in a dispute. Public guidance from contract manufacturers, as of 2026, is to scope exclusivity by product category, sales channel, geography and duration — and to treat it as something negotiated, not gifted.
- Category — exclusivity on one gummy format is not exclusivity on the whole range.
- Channel — retail, foodservice and e-commerce are different channels; name the one you actually sell in.
- Geography — "exclusive" in one market says nothing about another. Name the market.
- Duration — an exclusivity with no end date, or no performance condition attached, invites the argument it was never binding.
Write all four into the supply agreement, and connect them to a defined condition. What happens when the term ends, when volumes are not met, or when you want to move the program — those are the moments the clause is tested.

The check we run before we share a formula
Here is where our own history matters. We developed the 3D ice-sealed, peelable and crispy dual-color formats at our three R&D centers, filed patents on them, and only then opened those SKUs into the catalogue. We ran the same ownership check across our own formats that we ask a buyer to run on a custom program. We found the arguments almost never start at the printed pouch — they start at the sculpt and at the stability data behind the claim. We rejected the assumption that a waived development fee is simply goodwill; ownership that is not written down is ownership you will argue about later. We switched to naming three separate ownership lines — formula, mould and brand — in every custom agreement before a single sample is cut. That order of operations is not theory: a buyer who validates a market on an existing SKU starts with stability data that already exists, while a buyer who commissions a custom mould before any market test is learning a new product and a new market at the same time.
A clause-by-clause pre-signing checklist
Hand this list to whoever signs. Each line should have an answer in the document, not in an email thread.
- NDA signed and returned before full formula or detailed specs are shared.
- Formula ownership of the final version and all revisions stated explicitly.
- Modifications during scale-up — who owns them, named in advance.
- Tooling ownership, possession and collection trigger stated in the development agreement.
- Right to reuse the mould for another buyer addressed yes or no.
- Exclusivity defined by category, channel, geography and duration.
- Documentation package — COA, retained samples, stability plan — listed as a supply obligation.
- End-of-term terms — what transfers, what is returned, and on what condition.
If a line is met with "we always do that", ask for the sentence in the contract. A practice that is real will be written down.
What a factory should hand back
One reason ownership matters is that programs move. When a brand changes factory, the new factory cannot inherit a shelf-life claim without the file behind it. Open guidance as of 2026 lists the practical transfer package: the flavour-system reference or a written commitment that the flavour house will supply the same compound; tooling drawings with confirmation of who paid and who may collect them; artwork source files in an editable format; the stability protocol and data already generated; one retained production sample per lot; a named technical contact; and a written description of how the formula is protected. Our own answer on documentation is simpler to verify: every batch ships with a COA from our CNAS-accredited in-house laboratory, with full batch traceability. For the United States, a1 is an FDA-registered food facility — registration is not approval of any product.

Brand layer is a separate asset
Formula, mould and brand are three different assets and deserve three different clauses. Trademark, trade dress, artwork and photography are created and protected by different mechanisms from the recipe. Register the trademark in your own name in the markets you sell into, and settle artwork ownership and source-file delivery in writing before the first shipment. That is a separate conversation from formula IP, and it starts with the pack design — which is why we treat artwork and dieline control as its own pre-production decision. If you have not yet chosen between a catalog route and a fully custom program, read our custom versus private label comparison first: the ownership answer is different on each path.
MOQ and how to start
Start with the agreement structure, not the artwork. Sign the NDA, fix the development terms, define the three ownership lines, then commission samples. MOQ from 500 cartons per SKU, 200-carton trial orders for new markets. Our custom gummy manufacturing page sets out the development path; reach us through the contact page with your target market and product concept. On-pack claims, where relevant, follow the regulations of each target market — a factory can supply the format and the documentation, not a compliance opinion.
Frequently Asked Questions
Who owns the mould in gummy contract manufacturing? It depends on the development agreement, not on who paid the invoice alone. The document should state who paid for the tooling, who holds it, when it can be collected, and whether the factory may use the same mould for another buyer.
If the factory develops my formula, do I own it? Usually not by default. If the factory develops the formula or you start from a stock formula, ownership normally stays with the factory unless the agreement transfers it in writing. A right-to-use clause is not ownership.
Why must an exclusivity clause name four things? Because "exclusive" without a category, channel, geography and duration has no clear boundary. Define all four and attach a defined condition, or the promise is hard to enforce when it matters.
When should I sign an NDA? Before you share a formula, detailed specification or prototype. Share only broad product details at the inquiry stage, and release the full formula only to the factories you are seriously evaluating, after the NDA is signed and returned.
What documents should I get before signing? The three-agreement set (NDA, development, supply), a written formula and tooling ownership clause, a four-coordinate exclusivity clause if promised, and the documentation package — COA, retained samples and stability plan. Our batches carry a COA from our CNAS-accredited in-house lab with full traceability.
Bring the ownership questions to the first conversation, not the last. Final on-pack declarations and claims follow the regulations of each target market. Write to Katherine or Justin@a1food.cn, or WhatsApp +86-189-6548-2111.